INVIZYNE TECHNOLOGIES INC. COMMON STOCK
NASDAQ: IZTC (Invizyne Technologies Inc.)
Kemas kini terakhir: 7 jam lalu13.45
1.56 (13.12%)
Penutupan Terdahulu | 11.89 |
Buka | 12.38 |
Jumlah Dagangan | 16,905 |
Purata Dagangan (3B) | 41,237 |
Modal Pasaran | 128,162,360 |
Julat 52 Minggu |
Margin Operasi (TTM) | 704,833.69% |
EPS Cair (TTM) | -0.630 |
Nisbah Semasa (MRQ) | 0.250 |
Aliran Tunai Operasi (OCF TTM) | -3.58 M |
Aliran Tunai Bebas Leveraj (LFCF TTM) | -2.35 M |
Pulangan Atas Aset (ROA TTM) | -88.29% |
Arah Aliran Pasaran
Jangka Pendek | Jangka Sederhana | ||
Industri | Biotechnology (US) | Menurun | Menurun |
Biotechnology (Global) | Menurun | Menurun | |
Stok | Invizyne Technologies Inc. | - | - |
AISkor Stockmoo
Konsensus Penganalisis | -2.0 |
Aktiviti Orang Dalam | NA |
Volatiliti Harga | 2.0 |
Purata Bergerak Teknikal | 2.5 |
Osilator Teknikal | 0.0 |
Purata | 0.63 |
Invizyne Technologies Inc is redefining biomanufacturing by leveraging cell-free multi-step enzyme-based systems to efficiently transform natural or renewable resources into highly sought-after chemicals. It believes that its biomanufacturing platform, known as SimplePath, will be a significant alternative to the current methods of chemical compound production, which are generally chemical synthesis, natural extraction, and synthetic biology. its objective with SimplePath is to enable the efficient production of a diverse range of chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. Its platform consists of a series of modular cascading enzyme-based biomanufacturing systems that leverage natural processes to perform complex chemical conversions. |
|
Sektor | Healthcare |
Industri | Biotechnology |
% Dimiliki oleh Orang Dalam | 76.34% |
% Dimiliki oleh Institusi | 0.62% |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
Keuntungan Nyata | - |
Keuntungan Tidak Nyata | - |
Dividen Diterima 2025 | - |
Jumlah Untung | - |
Pulangan Purata | - |
Kuantiti (Beli) | - |
Purata Harga (Beli) | - |
Kuantiti (Jual) | - |
Purata Harga (Jual) | - |